abc27

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...
MarketWatch

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE(R) VIABAHN(R) FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP ...

The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...
BioSpace

InterVene, Inc. Announces First Patient Treated With the Recana™ Thrombectomy Catheter System

The Recana System is Designed for the Treatment of Venous In-Stent Restenosis and Native Vessel Obstructions REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVene, Inc., a medical device company pioneering ...
Business Wire

InterVene, Inc. Announces First Patient Treated With the Recana™ Thrombectomy Catheter System

REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVene, Inc., a medical device company pioneering interventional devices for venous inflow and outflow obstructions, announced today that the first patient ...
BioSpace

First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension

SAN MATEO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular ...
Endovascular Today

Route 92’s Monopoint Venous Sinus System Studied to Treat Idiopathic Intracranial Hypertension

March 19, 2025—Route 92 Medical, Inc. announced the results of a multicenter study evaluating the utility of the company’s Monopoint venous sinus system in neurovascular interventional procedures to ...
TMCnet

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial ...

HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company dedicated to the treatment of venous sinus stenosis, today announced the ...